Pharmacological treatment of sexual offenders – recent developments
This workshop will provide an extensive overview about all forms of pharmacological sexual offender treatment and will provide helpful suggestions concerning the question which sexual offender should be treated with which kind of pharmacological agent. Thereby, special emphasis will be laid on the presentation of current treatment guidelines for adult and adolescent sexual offenders. Furthermore, the ending of pharmacological treatment in a sexual offender will be discussed, a topic that has so far been mainly neglected. The theoretical parts will be supplemented with various case examples.
Daniel Turner (M.D., Ph.D.) is currently working as a medical resident at the Department of Psychiatry and Psychotherapy of the University Medical Center Mainz, Germany. Before that he was working at the Institute for Sex Research and Forensic Psychiatry at the University Medical Center Hamburg-Eppendorf. His current research interests involve the pharmacological treatment of sexual offenders, neuropsychological deficits in sexual offenders, and sexual behavior and sexual problems in adults with high-functional Autism Spectrum Disorders.